John D. Chisholm

2.5k total citations
85 papers, 1.8k citations indexed

About

John D. Chisholm is a scholar working on Organic Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, John D. Chisholm has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Organic Chemistry, 39 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in John D. Chisholm's work include Asymmetric Synthesis and Catalysis (15 papers), Catalytic C–H Functionalization Methods (12 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). John D. Chisholm is often cited by papers focused on Asymmetric Synthesis and Catalysis (15 papers), Catalytic C–H Functionalization Methods (12 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). John D. Chisholm collaborates with scholars based in United States, France and United Kingdom. John D. Chisholm's co-authors include William G. Kerr, Barry M. Trost, David L. Van Vranken, Stephen T. Wrobleski, Michael E. Jung, Paul E. Harrington, Arijit A. Adhikari, Christopher M. Russo, Sonia Iyer and Eric J. Gilbert and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

John D. Chisholm

79 papers receiving 1.8k citations

Peers

John D. Chisholm
Nigel J. Liverton United States
Jay Wrobel United States
Joel C. Barrish United States
Atli Thorarensen United States
John H. Hutchinson United States
Agnès Bombrun Switzerland
John D. Chisholm
Citations per year, relative to John D. Chisholm John D. Chisholm (= 1×) peers Ernest J. McEachern

Countries citing papers authored by John D. Chisholm

Since Specialization
Citations

This map shows the geographic impact of John D. Chisholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Chisholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Chisholm more than expected).

Fields of papers citing papers by John D. Chisholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Chisholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Chisholm. The network helps show where John D. Chisholm may publish in the future.

Co-authorship network of co-authors of John D. Chisholm

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Chisholm. A scholar is included among the top collaborators of John D. Chisholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Chisholm. John D. Chisholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Backe, Sarah J., Rebecca Sager, Michael Daneshvar, et al.. (2026). Targeting and dissociating HIF2α from the molecular chaperone Hsp70 triggers apoptosis in kidney cancer. Communications Medicine. 6(1). 91–91.
2.
Taft, Charles, et al.. (2025). A Modular Customizable Ligand-Conjugate (LC) System Targeting Ghrelin O-Acyltransferase. Biomolecules. 15(2). 204–204.
3.
Fernandes, Sandra, Raki Sudan, Christopher M. Russo, et al.. (2025). Aminocholestane and Aminoandrostane Inhibitors of the SH2 Domain‐Containing Inositol 5’‐Phosphatase (SHIP). ChemMedChem. 20(8). e202400597–e202400597.
4.
Das, Shibali, Surya Prakash Pandey, Raki Sudan, et al.. (2023). SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection. Cytokine. 171. 156373–156373. 4 indexed citations
5.
Sager, Rebecca, Sarah J. Backe, Diana M. Dunn, et al.. (2023). Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer. Cell chemical biology. 30(10). 1223–1234.e12. 8 indexed citations
6.
Fernandes, Sandra, Stewart N. Loh, Jeung‐Hoi Ha, et al.. (2022). Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microglia. iScience. 25(4). 104170–104170. 14 indexed citations
7.
Chisholm, John D., et al.. (2021). Esterifications with 2-(Trimethylsilyl)ethyl 2,2,2-Trichloroacetimidate. 2(1). 17–25. 1 indexed citations
8.
Chisholm, John D., et al.. (2019). Friedel-Crafts alkylation of indoles with trichloroacetimidates. Tetrahedron Letters. 60(19). 1325–1329. 7 indexed citations
9.
Fellows, Rachel, Christopher M. Russo, Catarina S. Silva, et al.. (2018). A multisubstrate reductase from Plantago major: structure-function in the short chain reductase superfamily. Scientific Reports. 8(1). 14796–14796. 11 indexed citations
10.
Gumbleton, Matthew, Raki Sudan, Sandra Fernandes, et al.. (2017). Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival. Science Signaling. 10(500). 31 indexed citations
11.
Dunn, Diana M., Rebecca Sager, Mark R. Woodford, et al.. (2017). Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer. Cell Reports. 21(7). 1883–1895. 40 indexed citations
12.
Srivastava, Neetu, Sonia Iyer, Raki Sudan, et al.. (2016). A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome. JCI Insight. 1(11). 26 indexed citations
13.
Fernandes, Sandra, Robert W. Brooks, Matthew Gumbleton, et al.. (2015). SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. EBioMedicine. 2(3). 205–213. 14 indexed citations
14.
Iyer, Sonia, et al.. (2014). SHIP1 Regulates MSC Numbers and Their Osteolineage Commitment by Limiting Induction of the PI3K/Akt/β-Catenin/Id2 Axis. Stem Cells and Development. 23(19). 2336–2351. 18 indexed citations
15.
Srivastava, Neetu, et al.. (2014). Impaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice. Mucosal Immunology. 7(6). 1429–1439. 27 indexed citations
16.
Chisholm, John D., et al.. (2012). Acute effects of weight training on glycaemia in type 1 diabetes. Practical Diabetes. 29(4). 155–159. 1 indexed citations
17.
Zhang, Changsheng, Christoph Albermann, Xun Fu, et al.. (2006). RebG‐ and RebM‐Catalyzed Indolocarbazole Diversification. ChemBioChem. 7(5). 795–804. 60 indexed citations
18.
Chisholm, John D., et al.. (2006). Palladium-catalyzed addition of alkynes to cyclopropenes. Chemical Communications. 632–632. 56 indexed citations
19.
Facompré, Michaël, Carolina Carrasco, Hervé Vezin, et al.. (2003). Indolocarbazole Glycosides in Inactive Conformations. ChemBioChem. 4(5). 386–395. 9 indexed citations
20.
Facompré, Michaël, Carolina Carrasco, Pierre Colson, et al.. (2002). DNA Binding and Topoisomerase I Poisoning Activities of Novel Disaccharide Indolocarbazoles. Molecular Pharmacology. 62(5). 1215–1227. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026